AU520250B2 - 4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds - Google Patents

4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds

Info

Publication number
AU520250B2
AU520250B2 AU35622/78A AU3562278A AU520250B2 AU 520250 B2 AU520250 B2 AU 520250B2 AU 35622/78 A AU35622/78 A AU 35622/78A AU 3562278 A AU3562278 A AU 3562278A AU 520250 B2 AU520250 B2 AU 520250B2
Authority
AU
Australia
Prior art keywords
phenyl
compound
carbon atoms
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU35622/78A
Other languages
English (en)
Other versions
AU3562278A (en
Inventor
G. W Adelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of AU3562278A publication Critical patent/AU3562278A/en
Application granted granted Critical
Publication of AU520250B2 publication Critical patent/AU520250B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU35622/78A 1977-05-02 1978-05-01 4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds Expired AU520250B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/792,616 US4069223A (en) 1977-05-02 1977-05-02 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
USUS792616 1977-05-02

Publications (2)

Publication Number Publication Date
AU3562278A AU3562278A (en) 1979-11-08
AU520250B2 true AU520250B2 (en) 1982-01-21

Family

ID=25157505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35622/78A Expired AU520250B2 (en) 1977-05-02 1978-05-01 4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds

Country Status (10)

Country Link
US (1) US4069223A (enExample)
JP (1) JPS549281A (enExample)
AU (1) AU520250B2 (enExample)
CA (1) CA1105465A (enExample)
DE (1) DE2819210A1 (enExample)
FR (1) FR2389605B1 (enExample)
GB (1) GB1581923A (enExample)
NL (1) NL7804725A (enExample)
SE (1) SE7805011L (enExample)
ZA (1) ZA782514B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53125944U (enExample) * 1977-12-22 1978-10-06
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
CA2443672C (en) * 2001-04-12 2011-03-29 Pharmacopeia, Inc. Aryl and biaryl piperidines used as mch antagonists
PL2368554T3 (pl) * 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
EP1749528A1 (en) 2005-08-05 2007-02-07 Pharma C S.A. Pharmaceutical combinations containing a mu opioid agonist and an inhibitor of NO production
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
JP5469593B2 (ja) 2007-03-29 2014-04-16 ワイス・エルエルシー 末梢性オピオイド受容体アンタゴニストおよびその使用
WO2008121348A2 (en) * 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1125112A (en) 1966-01-07 1968-08-28 Science Union & Cie New derivatives of diazabicyclo-decane and process for preparing them
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds

Also Published As

Publication number Publication date
JPS549281A (en) 1979-01-24
NL7804725A (nl) 1978-11-06
FR2389605A1 (enExample) 1978-12-01
FR2389605B1 (enExample) 1981-07-17
CA1105465A (en) 1981-07-21
US4069223A (en) 1978-01-17
ZA782514B (en) 1979-06-27
SE7805011L (sv) 1978-11-03
AU3562278A (en) 1979-11-08
GB1581923A (en) 1980-12-31
DE2819210A1 (de) 1979-02-08

Similar Documents

Publication Publication Date Title
AU509680B2 (en) 1,9-dihydroxyoctahydrophenanthrenes
AU521102B2 (en) 2, 6-diaminonebularines
AU545756B2 (en) Alpha-alkyl-alpha-phenyl-1h-1,2,4-triazole-1-ethanols
AU518983B2 (en) Hairspray
AU518432B2 (en) 3,4,5-trisubstituted-oxazolid and thiazolid-2-ones
AU3562278A (en) 4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds
AU517792B2 (en) 1, 2, 3-thiadiazol-3-in-5-ylidine ureas
AU521533B2 (en) 1, 2-benzisoxazolozyacetic acids and related compounds
AU526584B2 (en) 2,3-dicyanopyrazine derivatives
AU2668177A (en) 2, 6-Methano-2H-l-Benzoxocins
AU527943B2 (en) 2, 4-diamino-5-benzylpyrimidines
AU515140B2 (en) 2, 4, 7-triamino-pteridine derivatives
AU517664B2 (en) 4-phenyl-8-amino-tetrahydroisoquinolines
AU2477077A (en) 1,2,6-thidiazinones
AU2546577A (en) 5, 5-trimethylhexanoyl-ferrocene
AU512608B2 (en) 4'Homoisotwistane derivatives
AU518208B2 (en) 2,4-dichlorophenyl-triazolyl-ethan-one and -ol derivatives
AU515232B2 (en) A-nor-androsta-3(5)16 dien-2-ones
AU518292B2 (en) 1,4-benzoxathin-2-carboxamides
AU505664B2 (en) 2, 1, 3-benzothiadiazoles
AU517889B2 (en) 2, 6-METHANO-2H-l-BENZOXOCINS
AU516080B2 (en) 1, 2, 3-thiadiazolin-2-ide derivatives
AU514068B2 (en) 4'Deoxyvincristine and related compounds
IL55865A0 (en) 4-desacetoxy-4-oxovinblastine, 4-descetoxy-4-alpha-hydroxyvinblastine and related compounds
AU547833B2 (en) N,n:-bis-(2,3-digydroxypropyle-2,4,6-triiodo-5-)2-keto-l- gulonamido isophtalamide